These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 36999788)
1. Recent innovations in the screening and diagnosis of systemic sclerosis-associated interstitial lung disease. Makol A; Nagaraja V; Amadi C; Pugashetti JV; Caoili E; Khanna D Expert Rev Clin Immunol; 2023 Jun; 19(6):613-626. PubMed ID: 36999788 [TBL] [Abstract][Full Text] [Related]
2. Interstitial lung disease in systemic sclerosis: progress in screening and early diagnosis. Molberg Ø; Hoffmann-Vold AM Curr Opin Rheumatol; 2016 Nov; 28(6):613-8. PubMed ID: 27387267 [TBL] [Abstract][Full Text] [Related]
3. Detection and classification of systemic sclerosis-related interstitial lung disease: a review. DeMizio DJ; Bernstein EJ Curr Opin Rheumatol; 2019 Nov; 31(6):553-560. PubMed ID: 31415029 [TBL] [Abstract][Full Text] [Related]
4. Detection, screening, and classification of interstitial lung disease in patients with systemic sclerosis. Hoffmann-Vold AM; Molberg Ø Curr Opin Rheumatol; 2020 Nov; 32(6):497-504. PubMed ID: 32890027 [TBL] [Abstract][Full Text] [Related]
5. KL6 and IL-18 levels are negatively correlated with respiratory function tests and ILD extent assessed on HRCT in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD). Sieiro Santos C; Antolín SC; Lorenzo JC; Garay CL; Morales CM; de Miguel EB; Guerrero MR; Herránz LS; Álvarez ED Semin Arthritis Rheum; 2024 Apr; 65():152366. PubMed ID: 38290372 [TBL] [Abstract][Full Text] [Related]
6. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease. Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389 [TBL] [Abstract][Full Text] [Related]
7. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease. Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320 [TBL] [Abstract][Full Text] [Related]
8. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis. Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677 [TBL] [Abstract][Full Text] [Related]
9. [Interstitial lung disease in systemic sclerosis]. Mouthon L; Berezné A; Brauner M; Kambouchner M; Guillevin L; Valeyre D Presse Med; 2006 Dec; 35(12 Pt 2):1943-51. PubMed ID: 17159721 [TBL] [Abstract][Full Text] [Related]
10. Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD). Khedoe P; Marges E; Hiemstra P; Ninaber M; Geelhoed M Front Immunol; 2020; 11():1990. PubMed ID: 33013852 [TBL] [Abstract][Full Text] [Related]